PUVA, UVB, psoriasis, and nonmelanoma skin cancer - 12/10/17
Abstract |
This article reviews the English-language literature on the risk of nonmelanoma skin cancer from phototherapy (UVB) or photochemotherapy (PUVA) in the treatment of psoriasis. The evolution of the debate on the carcinogenic potential of these treatments is discussed, particularly with reference to PUVA. Available data indicate that therapeutic UVB has a low risk of producing cutaneous cancers, with the possible exception of those on male genital skin. However, there is a definite cutaneous carcinogenic risk from oral PUVA. The major associated risk factors are reviewed. We provide recommendations for the assessment and treatment of patients to minimize this risk.
Le texte complet de cet article est disponible en PDF.
Vol 29 - N° 6
P. 1013-1022 - décembre 1993 Retour au numéro
Article précédent
- A randomized, double-blind, placebo-controlled trial of ketoconazole 2% shampoo versus selenium sulfide 2.5% shampoo in the treatment of moderate to severe dandruff
- F. William Danby, W. Stuart Maddin, Lynette J. Margesson, Donald Rosenthal
- Delusional parasitosis: A dermatologic, psychiatric, and pharmacologic approach
- Marcia S. Driscoll, Marti Jill Rothe, Jane M. Grant-Kels, Mahlon S. Hale
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?